Pediatric Exploratory Research Study of EGCG Use and Safety (PERSEUS)

NACompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

January 29, 2018

Primary Completion Date

March 29, 2020

Study Completion Date

November 30, 2020

Conditions
Down SyndromeFragile X Syndrome
Interventions
DIETARY_SUPPLEMENT

EGCG FontUp

Intake of 10mg/kg/day of EGCG, in the form of a dietary supplement (FontUp), two times a day.

OTHER

Placebo FontUp

Intake of placebo, in the form of a dietary supplement (FontUp) (without EGCG), two times a day.

Trial Locations (1)

08003

IMIM (Institut Hospital del Mar d'Investigacions Mèdiques), Barcelona

All Listed Sponsors
collaborator

Hospital Infantil Universitario Niño Jesús, Madrid, Spain

OTHER

collaborator

Instituto Hispalense de Pediatría, Sevilla, Spain

UNKNOWN

collaborator

Hospital Universitario Marqués de Valdecilla

OTHER

collaborator

Institut Jerome Lejeune

OTHER

lead

Parc de Salut Mar

OTHER

NCT03624556 - Pediatric Exploratory Research Study of EGCG Use and Safety (PERSEUS) | Biotech Hunter | Biotech Hunter